Role of the β

Acute kidney injury Formoterol β2-adrenergic receptor

Journal

Pharmacological reports : PR
ISSN: 2299-5684
Titre abrégé: Pharmacol Rep
Pays: Switzerland
ID NLM: 101234999

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 07 12 2023
accepted: 03 04 2024
revised: 28 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: aheadofprint

Résumé

Podocytes have a remarkable ability to recover from injury; however, little is known about the recovery mechanisms involved in this process. We recently showed that formoterol, a long-acting β We genetically deleted the β A similar level of injury was observed in β These results indicate that the podocyte β

Sections du résumé

BACKGROUND BACKGROUND
Podocytes have a remarkable ability to recover from injury; however, little is known about the recovery mechanisms involved in this process. We recently showed that formoterol, a long-acting β
METHODS METHODS
We genetically deleted the β
RESULTS RESULTS
A similar level of injury was observed in β
CONCLUSIONS CONCLUSIONS
These results indicate that the podocyte β

Identifiants

DOI: 10.1007/s43440-024-00594-5 PMID: 38668812
pubmed: 38668812
doi: 10.1007/s43440-024-00594-5
pii: 10.1007/s43440-024-00594-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01DK087956
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56DK116887
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30DK074038
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM084147
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Reiser J, Altintas MM. Podocytes. F1000Res. 2016;5:114.
doi: 10.12688/f1000research.7255.1
Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008;88(2):451–87.
doi: 10.1152/physrev.00055.2006 pubmed: 18391170
Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol. 2013;9(6):328–36.
doi: 10.1038/nrneph.2013.78 pubmed: 23609563
Lal MA, Patrakka J. Understanding podocyte biology to develop novel kidney therapeutics. Front Endocrinol. 2018;9:409.
doi: 10.3389/fendo.2018.00409
Torban E, Braun F, Wanner N, Takano T, Goodyer PR, Lennon R, et al. From podocyte biology to novel cures for glomerular disease. Kidney Int. 2019;96(4):850–61.
doi: 10.1016/j.kint.2019.05.015 pubmed: 31420194
Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens. 2006;15(1):1–7.
doi: 10.1097/01.mnh.0000199012.79670.0b pubmed: 16340659
Bhargava P, Janda J, Schnellmann RG. Elucidation of cGMP-dependent induction of mitochondrial biogenesis through PKG and p38 MAPK in the kidney. Am J Physiol Renal Physiol. 2020;318(2):F322–8.
doi: 10.1152/ajprenal.00533.2019 pubmed: 31841384
Arif E, Nihalani D. Beta2-adrenergic receptor in kidney biology: a current prospective. Nephrology. 2019;24(5):497–503.
doi: 10.1111/nep.13584 pubmed: 30848004
Cameron RB, Gibbs WS, Miller SR, Dupre TV, Megyesi J, Beeson CC, et al. Proximal tubule beta 2-adrenergic receptor mediates formoterol-induced recovery of mitochondrial and renal function after ischemia-reperfusion injury. J Pharmacol Exp Ther. 2019;369(1):173–80.
doi: 10.1124/jpet.118.252833 pubmed: 30709866
Johnstone DB, Zhang JZ, George B, Leon C, Gachet C, Wong H, et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Biol. 2011;31(10):2162–70.
doi: 10.1128/MCB.05234-11 pubmed: 21402784 pmcid: 3133349
Hizawa N. Pharmacogenetics of beta2-agonists. Allergol Int. 2011;60(3):239–46.
doi: 10.2332/allergolint.11-RAI-0317 pubmed: 21681016
Syamsu, Yusuf I, Patellongi I. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients. Acta Med Indones. 2007;39(1):8–12.
pubmed: 17297203
Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol. 2006;117(1):18–24.
doi: 10.1016/j.jaci.2005.11.012 pubmed: 16387578
Wachter SB, Gilbert EM. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology. 2012;122(2):104–12.
doi: 10.1159/000339271 pubmed: 22759389
Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, et al. Mitochondrial biogenesis induced by the beta2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019;96(3):656–73.
doi: 10.1016/j.kint.2019.03.023 pubmed: 31262488 pmcid: 6708766
Solanki AK, Srivasta P, Rahman B, Lipschutz JH, Nihalani D, Arif E. The Use of high-throughput transcriptomics to identify pathways with therapeutic significance in podocytes. Int J Mol Sci. 2020;21(1):274.
doi: 10.3390/ijms21010274
Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Meyers MG, et al. The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol. 2008;183(7):1235–42.
doi: 10.1083/jcb.200809113 pubmed: 19103808 pmcid: 2606962
Scholpa NE, Simmons EC, Tilley DG, Schnellmann RG. Beta2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury. Exp Neurol. 2019;322: 113064.
doi: 10.1016/j.expneurol.2019.113064 pubmed: 31525347 pmcid: 7751764
Velez JCQ, Arif E, Rodgers J, Hicks MP, Arthur JM, Nihalani D, et al. Deficiency of the angiotensinase aminopeptidase A increases susceptibility to glomerular injury. J Am Soc Nephrol. 2017;28(7):2119–32.
doi: 10.1681/ASN.2016111166 pubmed: 28202497 pmcid: 5491295
Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest. 2006;116(5):1346–59.
doi: 10.1172/JCI27414 pubmed: 16543952 pmcid: 1401486
Arif E, Rathore YS, Kumari B, Ashish F, Wong HN, Holzman LB, et al. Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury. J Biol Chem. 2014;289(14):9502–18.
doi: 10.1074/jbc.M113.505743 pubmed: 24554715 pmcid: 3975002
Sagar A, Arif E, Solanki AK, Srivastava P, Janech MG, Kim SH, et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep. 2017;7(1):12047.
doi: 10.1038/s41598-017-12134-8 pubmed: 28935902 pmcid: 5608913
Masszi A, Fan LF, Rosivall L, McCulloch CA, Rotstein OD, Muscsi I, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol. 2004;165(6):1955–67.
doi: 10.1016/S0002-9440(10)63247-6 pubmed: 15579439 pmcid: 1618715
Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 1998;54(3):864–76.
doi: 10.1046/j.1523-1755.1998.00076.x pubmed: 9734611
Lopes TG, Souza ML, Silva VD, Santos MD, Silva WIC, Itaquy TP, et al. Markers of renal fibrosis: how do they correlate with podocyte damage in glomerular diseases? PLoS ONE. 2019;14(6): e0217585.
doi: 10.1371/journal.pone.0217585 pubmed: 31220088 pmcid: 6586273
Muller-Deile J, Schiffer M. Podocytes from the diagnostic and therapeutic point of view. Pflugers Arch. 2017;469(7–8):1007–15.
doi: 10.1007/s00424-017-1993-z pubmed: 28508947
Faul C, Connelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14(9):931–8.
doi: 10.1038/nm.1857 pubmed: 18724379 pmcid: 4109287
Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D’Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. 2000;58(2):674–83.
doi: 10.1046/j.1523-1755.2000.00213.x pubmed: 10916090
Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int. 2012;81(1):40–55.
doi: 10.1038/ki.2011.306 pubmed: 21937979

Auteurs

Ehtesham Arif (E)

Department of Medicine, Nephrology Division, Medical University of South Carolina, Clinical Science Building 822N, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA.

Ashish K Solanki (AK)

Department of Medicine, Nephrology Division, Medical University of South Carolina, Clinical Science Building 822N, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA.

Bushra Rahman (B)

Department of Medicine, Nephrology Division, Medical University of South Carolina, Clinical Science Building 822N, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA.

Bethany Wolf (B)

Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.

Rick G Schnellmann (RG)

Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA.
Southern Arizona VA Health Care System, Tucson, AZ, USA.

Deepak Nihalani (D)

Department of Medicine, Nephrology Division, Medical University of South Carolina, Clinical Science Building 822N, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA.

Joshua H Lipschutz (JH)

Department of Medicine, Nephrology Division, Medical University of South Carolina, Clinical Science Building 822N, 96 Jonathan Lucas Street, Charleston, SC, 29425, USA. Lipschut@musc.edu.

Classifications MeSH